SACRAMENTO, Calif., March 2 /PRNewswire/ -- Ventria Bioscience has announced the introduction of a new, animal-free recombinant bacterial cell lysis agent for use in diagnostic applications, bioprocessing and life science research. Lysobac(TM) provides consistent high performance cell lysis without the risk of adding an animal component. Lysobac(TM) outperforms the competition with significantly higher lysing activity compared with other lysing agents.
“We are excited about Lysobac(TM)'s ability to improve the productivity and safety of bacterial production systems,” said Scott Deeter, President and CEO, Ventria Bioscience.
“We are very impressed by the high level of lysing activity we have seen with Lysobac(TM),” said Ning Huang, Vice President of Research and Development, Ventria Bioscience.
Ventria Bioscience will market Lysobac(TM) to companies that seek a cost effective, high performing cell lysis agent. In addition to Lysobac(TM), Ventria also produces Lacromin(TM) for the cell culture market.
About Lysobac(TM)
Lysobac(TM) is recombinant human lysozyme derived from plants. Lysobac(TM) holds many advantages over other lysing agents:
-- Free of Animal Derived Components Since Lysobac(TM) is produced in an animal-free system, it is free of infectious contaminants from animal origin. -- Proven Consistent Results Lysobac(TM) is a recombinant protein that provides consistent cell lysis results, so process changes are minimized. -- Bioprocessing Efficiency For bioprocessing applications, Lysobac(TM) saves time by eliminating extra steps in the production process by enabling in-culture protein extraction. In addition because Lysobac(TM) is highly active it adds minimal volume to the final lysate. -- High Performance Lysobac(TM) is 4 times more active per mg for lysing Micrococcus and E. coli., when compared with chicken lysozyme. -- Superior Economics Ventria’s efficient production methods and Lysobac(TM)'s high activity levels combine to reduce overall costs when compared with chicken lysozyme. -- Gentle Lysing Agent Lysobac(TM) is a gentle lysing agent providing minimal risk of denaturing the protein product.
Lysobac(TM) is offered for sale from Ventria Bioscience in 100 million, 1 billion, 10 billion, and 100 billion unit package sizes. Pricing of Lysobac(TM) is available upon request.
For more information about Lysobac(TM), see our website at http://www.lysobac.com
Statements in this announcement other than historical data and information constitute forward looking statements that involve risks and uncertainties that could cause actual results to differ materially from those stated or implied by such forward-looking statements. Potential risks and uncertainties may include, but are not limited to, recent changes in senior management, fluctuations in operating results, market conditions and changes in technology and increased competition.
Ventria Bioscience
CONTACT: Ventria Bioscience, +1-916-921-6148, or info@ventria.com
Web site: http://www.ventria.com/
